LIVE EVENT: The U.S. healthcare law rollout: Where do we stand?
WASHINGTON - Vice President Joe Biden will announce on Tuesday a new push to increase access to mental health services with $100 million in new government funding a year after the school shooting in Newtown, Connecticut, sparked a failed push for stronger gun control measures.
MARSEILLE - The founder of a French breast implant company was sentenced to four years in prison by a Marseille criminal court on Tuesday for hiding the true nature of the sub-standard silicone used in implants sold to 300,000 women around the world.
COPENHAGEN - Novo Nordisk, the world's largest insulin maker, is facing a Danish police probe after it was reported by the financial watchdog for not disclosing at once that its big new product hope Tresiba had been refused U.S. approval.
WASHINGTON - The U.S. Supreme Court on Monday left intact a $142 million jury verdict against Pfizer Inc over the marketing of the epilepsy drug Neurontin.
TEL AVIV - Teva Pharmaceutical Industries, the world's biggest maker of generic drugs, estimates its pipeline of so-called new therapeutic entities (NTEs) could generate revenue of $1 billion to $1.5 billion by 2018.
NEW YORK (Reuters Health) - Every hour, on average, a child ends up in a U.S. emergency room with an injury associated with a high chair, according to a new study. And the risk seems to be rising.
NEW YORK (Reuters Health) - Regular exercise can help people with dementia think a little more clearly, and care for themselves a bit more, a new study finds.
NEW YORK - Merck & Co Inc said on Monday that it was prepared to pay $27.7 million to settle lawsuits by hundreds of people who sued the company over allegations that its osteoporosis drug Fosamax caused bones in the jaw to deteriorate.
COPENHAGEN - Novo Nordisk received European Union marketing authorization for its hemophilia drug NovoEight on November 13 2013, the Danish pharmaceutical company said on Monday.
- An advisory panel of medical experts on Monday voted to recommend that U.S. health regulators approve an experimental drug for ulcerative colitis and Crohn's disease developed by Takeda Pharmaceutical Co.
On Wednesday, December 4 at 10:30 a.m. watch live as experts assess where the U.S. stands in the healthcare law rollout and the resulting health policy implications. Presented by the forum at Harvard School of Public Health in collaboration with Reuters. Live Coverage